Palisade Capital Management LP Buys New Shares in Integer Holdings Corporation $ITGR

Palisade Capital Management LP purchased a new position in shares of Integer Holdings Corporation (NYSE:ITGR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 103,179 shares of the medical equipment provider’s stock, valued at approximately $9,642,000. Palisade Capital Management LP owned about 0.30% of Integer as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in Integer during the 2nd quarter valued at about $29,000. EverSource Wealth Advisors LLC increased its stake in Integer by 48.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 117 shares during the period. Harbor Investment Advisory LLC bought a new stake in Integer in the second quarter valued at approximately $42,000. TD Private Client Wealth LLC lifted its position in Integer by 1,037.5% in the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 415 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its stake in shares of Integer by 135.5% during the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ITGR shares. Truist Financial cut shares of Integer from a “buy” rating to a “hold” rating and boosted their price objective for the company from $110.00 to $127.00 in a research report on Monday, August 3rd. Benchmark cut Integer from a “buy” rating to a “hold” rating in a research note on Thursday, August 13th. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Zacks Research upgraded Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Finally, Freedom Capital lowered Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th. One research analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $109.86.

Integer Trading Up 0.3%

NYSE:ITGR opened at $125.45 on Wednesday. The company has a 50-day moving average price of $105.49 and a 200-day moving average price of $93.71. The stock has a market cap of $4.26 billion, a price-to-earnings ratio of 34.28, a P/E/G ratio of 2.95 and a beta of 0.61. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $126.14.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. During the same quarter in the previous year, the company earned $1.55 earnings per share. Integer’s quarterly revenue was down 2.6% on a year-over-year basis. Equities analysts predict that Integer Holdings Corporation will post 6.09 EPS for the current year.

Key Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Zacks raised its fiscal 2026 EPS estimate to $6.13 from $6.05, above the current consensus estimate of $6.08. This improvement may be supporting investor confidence in Integer’s near-term earnings outlook. Integer Holdings analyst estimate update
• Positive Sentiment: The firm also modestly increased its Q2 2027 EPS estimate to $1.61 from $1.60 and Q1 2028 EPS to $1.71 from $1.65, indicating some confidence in selected periods of future growth. Integer Holdings earnings estimate revisions
• Neutral Sentiment: Zacks maintained a Hold rating on Integer. Its estimates imply EPS of $6.56 for fiscal 2027 and $6.85 for fiscal 2028, suggesting continued earnings growth but not enough conviction for a more bullish rating. Zacks rating on Integer Holdings
• Negative Sentiment: Zacks reduced estimates for Q3 and Q4 2026 EPS to $1.63 and $1.70, respectively, from $1.68 and $1.77. It also cut fiscal 2027 EPS to $6.56 from $6.87 and fiscal 2028 EPS to $6.85 from $7.20. These downward revisions point to a softer longer-term earnings trajectory and may weigh on valuation. Integer Holdings downward EPS revisions

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.